Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (5) , 592-600
- https://doi.org/10.1016/s0168-8278(02)00231-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central MassachusettsPharmacoepidemiology and Drug Safety, 1999
- Venlaxafine-Associated HepatitisAnnals of Internal Medicine, 1999
- Drug points: Hepatotoxicity associated with zolpidem treatmentBMJ, 1999
- Hepatic Injury Caused by AcarboseAnnals of Internal Medicine, 1996
- Risperidone-Associated HepatotoxicityJournal of Clinical Psychopharmacology, 1996
- Taming the brain storms: felbamate updatedThe Lancet, 1995
- Drug points: Fulminant hepatic failure induced by lamotrigineBMJ, 1995
- Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspectiveClinical Pharmacology & Therapeutics, 1995
- Drug-induced acute liver diseasePharmacoepidemiology and Drug Safety, 1993
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990